Xtant Medical (NYSEAMERICAN:XTNT) Stock Crosses Above 200-Day Moving Average – Time to Sell?

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.62. Xtant Medical shares last traded at $0.59, with a volume of 14,499 shares trading hands.

Xtant Medical Stock Performance

The stock has a market cap of $77.85 million, a P/E ratio of -4.31 and a beta of 0.35. The company has a current ratio of 2.12, a quick ratio of 0.88 and a debt-to-equity ratio of 0.42.

Hedge Funds Weigh In On Xtant Medical

A hedge fund recently raised its stake in Xtant Medical stock. Renaissance Technologies LLC lifted its holdings in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) by 15.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 798,033 shares of the medical device company’s stock after purchasing an additional 103,825 shares during the period. Renaissance Technologies LLC owned about 0.57% of Xtant Medical worth $354,000 at the end of the most recent reporting period. Institutional investors own 69.33% of the company’s stock.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.